Closing the Osteoporosis Care Gap: Improving Screening, Risk Stratification, and Evidence-Based Management (2026 AC Live)

Only available as part of a package

This activity is supported by an educational grant from Radius Health/Paratek Pharmaceuticals

Learning Objectives:

Apply guideline-recommended osteoporosis screening strategies to identify patients at risk for osteoporosis and fragility fractures, including older adults, men, and individuals with secondary causes of bone loss.
Recognize fragility fractures as a sentinel event and implement timely evaluation and secondary fracture prevention strategies to reduce imminent and long-term fracture risk.
Utilize fracture risk stratification tools to categorize patients by low, high, and very high fracture risk and translate risk assessment into evidence-based treatment decisions.

Shine Vazhappilly, MD

Rheumatologist

St. Elizabeth Healthcare

Shine Vazhappilly, MD, is a rheumatologist at St. Elizabeth Healthcare in Northern Kentucky. She completed her Rheumatology fellowship at HCA Florida Trinity Hospital and her Internal Medicine residency at The Jewish Hospital in Cincinnati.

Her areas of clinical interest include osteoporosis and metabolic bone disease, interstitial lung disease, and rheumatologic issues arising in oncologic conditions.

Dr. Vazhappilly has substantial experience in the evaluation and treatment of patients with osteoporosis and other disorders of bone health, including fracture-risk assessment and the use of antiresorptive and anabolic therapies. She completed the International Society for Clinical Densitometry (ISCD) Quality Bone Densitometry: Performance, Interpretation and Clinical Application for Clinicians course, with focused training in DXA acquisition, interpretation, and clinical application. She has also previously served as an advisor on a research study involving osteoporosis pharmacologic therapy.